Costco recalls chicken products as Listeria meat recalls increase at BrucePac

Another day, another contaminated food product for Americans to be on the lookout for. This time it's from Costco (COST-0.25%)which told customers earlier this month that some of its ready-to-eat meal packages may have been contaminated Listeria.

Costco alerted customers to the recall for products that include Rana Chicken Truffle Carbonara and Tagliatelle Grilled White Chicken & Portabello Mushroom Sauce a letter dated October 11th This became public in news reports on Friday.

“Costco's records indicate that you or one of your additional members purchased one or more of items 1844072 Rana Chicken Truffle Carbonara and/or 1102200 Tagliatelle Grilled White Chicken & Portobello Mushroom Sauce between September 2024 and October 2024,” the retailer said wrote in the letter.

It offers full refund to the buyers of the products.

The Costco products join a list of frozen foods sold by other retailers including Walmart, Trader Joe's and Amazonand add Millions of pounds of meat have been recalled last week due to listeria concerns.

The recall warning was triggered by a voluntary recall by BrucePac Foods, a Costco chicken product supplier, based on the discovery of listeria. Some of the chicken was used in Rana Meal Solutions meal kits.

Read more: A meat recall due to listeria has grown to 12 million pounds. 15 products are affected here

Listeria monocytogenes can cause serious listeriosis infections in young children, the elderly, and people with weakened immune systems. The FDA also warns that listeria infections can cause miscarriages and stillbirths in pregnant women. Even in healthy people, a listeria infection can cause symptoms such as high fever, headache, stiffness, nausea, abdominal pain and diarrhea.

Food safety consultant and Northeastern University professor Dr. Darin Detwiler, said there have been more listeria warnings because testing for the bacteria has made it easier to detect. But there There were other factors toosuch as a massive restructuring at the Food and Drug Administration.

“What we are seeing is likely a perfect storm of factors: regulatory transitions, pandemic-related inspection gaps, increased detection capabilities and economic pressures,” he said. “Taken together, these elements have led to an increase in recalls.”

— Francisco Velasquez and Bruce Gil contributed to this article.